Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H24ClN3O3 |
| Molecular Weight | 401.887 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(CC(=O)N1CCOCC1)CC2=C(Cl)C=CC=C2NC(=O)C3=CC=CC=C3
InChI
InChIKey=KSNNEUZOAFRTDS-UHFFFAOYSA-N
InChI=1S/C21H24ClN3O3/c1-24(15-20(26)25-10-12-28-13-11-25)14-17-18(22)8-5-9-19(17)23-21(27)16-6-3-2-4-7-16/h2-9H,10-15H2,1H3,(H,23,27)
| Molecular Formula | C21H24ClN3O3 |
| Molecular Weight | 401.887 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.medicamentos.com.mx/DocHTM/31249.htm
Sources: http://www.medicamentos.com.mx/DocHTM/31249.htm
Fominoben is a medication indicated for the treatment of dry cough. The drug was marketed under the name Noleptan, however, its current status is unknown and supposed to be "discontinued".
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.medicamentos.com.mx/DocHTM/31249.htm
One pill 2-3 times a day.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:35:01 GMT 2025
by
admin
on
Mon Mar 31 18:35:01 GMT 2025
|
| Record UNII |
TJ2KK6NYJS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C170002
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL1697837
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
1234
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
DB08968
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
DTXSID1023075
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
3260
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
TJ2KK6NYJS
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
241-964-4
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
100000080411
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
m5525
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
C073322
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
18053-31-1
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
SUB07777MIG
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
183875
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | RxNorm | ||
|
Fominoben
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY | |||
|
3407
Created by
admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |